News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen – ESMO Open
Photo generated from www.esmoopen.com
Mar 21, 2024, 10:54

The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen – ESMO Open

ESMO Open posted on X:

“Hot off the press: among 757 patients with early HER2+ breast cancer in the Swedish SCAN-B cohort, the HER2DX risk-score as a continuous variable was found significantly associated with OS after adjustment for clinical variables and treatment regimen.”

The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open

Read Further
Source: ESMO Open/X

Breast Cancer ESMO ESMO Open HER2 HER2DX risk-score OncoDaily Oncology Swedish SCAN-B cohort
Special Coverage
Voices
Aug 28, 2025, 20:24
Mohamed Emam Sobeih: International Guidelines on NUT Carcinoma
Blog Posts
Aug 28, 2025, 20:04
Michelle Mitchell: One Cancer Voice Calls for a National Cancer Plan
Voices
Aug 28, 2025, 20:00
Cynthia Jordan: Protecting Access to DCISionRT for Ductal Carcinoma Patients
Positive
Aug 28, 2025, 19:54
Honored to Host WHO and St. Jude Children's Research Hospital - The Indus Hospital
Voices
Aug 28, 2025, 19:40
The Countdown to the 2025 Global Summit and Award Ceremonies Is On - NFCR
Societies
Aug 28, 2025, 19:36
European Commission Opens Working Group on Lung Cancer Screening and Care - ECO
Voices
Aug 28, 2025, 19:29
Missed ESMO Academy 2025 or Want to Revisit the Highlights?
Insight
Aug 28, 2025, 19:18
Susanna Fletcher Greer: Bold Research on CD40 Immunotherapy Shows Promising Results
Blog Posts
Aug 28, 2025, 19:07
Norman Ng: A New Chapter in Hong Kong's Drug Approval
Blog Posts
Aug 28, 2025, 18:56
Tracey O'Brien: Honored to Contribute to Research Australia’s INSPIRE Magazine
Voices
Aug 28, 2025, 18:48
Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy - EACR
Science
Aug 28, 2025, 18:46
Moazzam Shahzad Shares New Insights on AlloHCT in Elderly Myelofibrosis Patients